Literature DB >> 10971821

RNA-dependent RNA polymerase activity encoded by GB virus-B non-structural protein 5B.

W Zhong1, P Ingravallo, J Wright-Minogue, A S Uss, A Skelton, E Ferrari, J Y Lau, Z Hong.   

Abstract

Phylogenetic analysis and polyprotein organization comparison have shown that GB virus-B (GBV-B) is closely related to hepatitis C virus (HCV). In this study, the coding region for GBV-B non-structural protein 5B (NS5B) was isolated by reverse transcription-polymerase chain reaction (RT-PCR) from pooled serum of GBV-B-infected tamarins. Expression of soluble GBV-B NS5B protein in Escherichia coli was achieved by removal of a 19-amino acid hydrophobic domain at the C-terminus of the protein. The truncated GBV-B NS5B (NS5BDeltaCT19) was purified to homogeneity and shown to possess an RNA-dependent RNA polymerase (RdRp) activity in both gel-based and scintillation proximity assays. NS5BDeltaCT19 required the divalent cation Mn2+ for enzymatic activity, at an optimal concentration of 15 mM. Interestingly, Mg2+, at concentrations up to 20 mM, did not support the GBV-B NS5B activity. This differs from HCV NS5B where both Mn2+ and Mg2+ can support RdRp activity. Zn2+ was found to inhibit the activity of GBV-B NS5B, with a 50% inhibitory concentration (IC50) of 5-10 microM. Higher concentrations of monovalent salts (NaCl or KCl > 100 mM) and glycerol (> 3%) were also inhibitory. NS5BDeltaCT19 was able to bind to RNA homopolymers, but utilized most efficiently poly(C), the one with the lowest binding affinity for RNA synthesis. Mutational analysis of GBV-B NS5B demonstrated the importance of several conserved sequence motifs for enzymatic activity. Based on sequence homology ( approximately 37% identity and 52% similarity) between GBV-B and HCV NS5B proteins, the active GBV-B RdRp provides a good surrogate assay system for HCV polymerase studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971821     DOI: 10.1046/j.1365-2893.2000.00226.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  8 in total

1.  Requirements for de novo initiation of RNA synthesis by recombinant flaviviral RNA-dependent RNA polymerases.

Authors:  C T Ranjith-Kumar; Les Gutshall; Min-Ju Kim; Robert T Sarisky; C Cheng Kao
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Regulated and liver-specific tamarin alpha interferon gene delivery by a helper-dependent adenoviral vector.

Authors:  Luigi Aurisicchio; Amedeo De Tomassi; Nicola La Monica; Gennaro Ciliberto; Cinzia Traboni; Fabio Palombo
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Cell clones selected from the Huh7 human hepatoma cell line support efficient replication of a subgenomic GB virus B replicon.

Authors:  Amedeo De Tomassi; Maura Pizzuti; Rita Graziani; Andrea Sbardellati; Sergio Altamura; Giacomo Paonessa; Cinzia Traboni
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors.

Authors:  Helen Bright; Anthony R Carroll; Paul A Watts; Robert J Fenton
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin.

Authors:  Jae-Hwan Nam; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Marisa St Claire; Jens Bukh
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  The modeled structure of the RNA dependent RNA polymerase of GBV-C virus suggests a role for motif E in Flaviviridae RNA polymerases.

Authors:  François Ferron; Cécile Bussetta; Hélène Dutartre; Bruno Canard
Journal:  BMC Bioinformatics       Date:  2005-10-14       Impact factor: 3.169

7.  De novo RNA synthesis and homology modeling of the classical swine fever virus RNA polymerase.

Authors:  Pengwei Zhang; Jian Xie; Guanghui Yi; Chuyu Zhang; Rong Zhou
Journal:  Virus Res       Date:  2005-04-15       Impact factor: 3.303

8.  Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Authors:  Pantxika Bellecave; Christian Cazenave; Julie Rumi; Cathy Staedel; Ophélie Cosnefroy; Marie-Line Andreola; Michel Ventura; Laura Tarrago-Litvak; Thérèse Astier-Gin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.